ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0073

PD-1hi Cells Are Highly Present in the Rheumatoid Joint, and Express Regulatory Capacities

Sofie Rask1, Christian Andersen2, Malene Hvid1, Kim Ravnskjær2, Bent Deleuran1 and Stinne Greisen3, 1Aarhus University, Aarhus, Denmark, 2University of Southern Denmark, Odense, Denmark, 3Aarhus University/Aarhus University Hospital, Aarhus, Denmark

Meeting: ACR Convergence 2023

Keywords: osteoblast, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0066–0095) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Programmed death 1 (PD-1) is an immune checkpoint receptor expressed by activated T cells, and of major importance in maintaining peripheral tolerance. Expression of PD-1 has been associated with T cells exhaustion, plasma cell differentiation and bone homeostasis. With emerging treatments engaging the PD-1 pathway in Rheumatoid Arthritis (RA) this pathway is of continued interest.

We aimed to investigate PD-1hi T cells from RA synovial fluid (SF).

Methods: SF was collected from RA patients with disease flare (n=7). Cells were stained for flow and sorted in CD3+ PD-1hi/PD-1lo populations. Post sorting, bulk RNA seq was performed, and cells were stimulated with antiCD3/CD28. Cytokines in the supernatants were investigated using V-plex multipanel assay. Supernatants were added to fibroblast cultures and the osteoblast cell line SaOs-2.

Results: Evaluated by flow cytometry, PD-1+ cells represented 42% of CD4+ T cells and 34% of CD8+ T cells in the SF. When comparing co-expression of checkpoint receptors and transcription factors between PD-1hi and PD-1lo CD4+ T cell; Tigit, Tim3 and NFAT were all increased in PD-1hi (all p < 0.05), Lag-3 was slightly elevated (p=0.07), whereas TCF1 and TOX expression did not differ. These differences were not observed between PD-1hi and PD-1lo CD8+ T cells.

Post sorting, RNAseq revealed PD-1hi and PD-1lo cells to cluster separately. In PD-1hi cells, gene expression corresponded to structural signatures, including tubulin binding and cytoskeletal motor activity (p < 0.01). Genes related to peripheral T helper cells, including IL21 and CXCL13 were highly upregulated (all p< 0.05) The gene PHEX was highly expressed (log2 fold change=5.2), suggesting an association with bone mineralization. The signature in PD-1lo cells was associated with immune activation genes (p < 0.005). Stimulating cells with CD3/CD28 post sorting resulted in lower production of IL-2, IFNg, TNFa, IL-8, IL-10, IL-13, IL-12, and IL-1b from PD-1hi cells compared to PD-1lo. The supernatant from PD-1hi cells only slightly activated fibroblasts, whereas the PD-1lo supernatant significantly activated fibroblasts, as measured by by MCP-1 production and surface ICAM expression (fig 1). When adding the PD-1hi and PD-1lo supernatant to osteoblast cultures, bone mineralization was significantly increased by the PD-1hi supernatant (fig 2).

Conclusion: PD-1hi cells are present in the synovial joint. They are not exhausted but express multiple checkpoint receptors, suggesting regulatory capacities. They could play a central role in structural maintenance through effects on fibroblasts and osteoblasts.

Supporting image 1

Fig 1: Left: Expression of ICAM on fibroblasts after culturing with PD_1 hi/PD_1lo supernatant. IFNg used as a positive control. Right: MCP_1 production measured in the supernatant from fibroblasts after culturing with PD_1 hi/PD_1lo supernatant. IFNg used as a positive control.

Supporting image 2

Mineralization measured in the SaOs_2 osteoblast cell line after culturing with PD_1hi and PD_1lo supernatant. Data are normalized to the cell line in growth media.


Disclosures: S. Rask: None; C. Andersen: None; M. Hvid: None; K. Ravnskjær: Thermo Fisher, 3; B. Deleuran: None; S. Greisen: None.

To cite this abstract in AMA style:

Rask S, Andersen C, Hvid M, Ravnskjær K, Deleuran B, Greisen S. PD-1hi Cells Are Highly Present in the Rheumatoid Joint, and Express Regulatory Capacities [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/pd-1hi-cells-are-highly-present-in-the-rheumatoid-joint-and-express-regulatory-capacities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pd-1hi-cells-are-highly-present-in-the-rheumatoid-joint-and-express-regulatory-capacities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology